Carmen Fernandez-Alvarez

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+ lymphoma.

HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+ lymphoma.

Journal: Blood

Published: September 03, 2024

Correction to: High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion.

Correction to: High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion.

Journal: Cancer gene therapy

Published: December 02, 2022

High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion.

High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion.

Journal: Cancer gene therapy

Published: May 02, 2022

CAR T-Cell Therapy Predictive Response Markers in Diffuse Large B-Cell Lymphoma and Therapeutic Options After CART19 Failure.

CAR T-Cell Therapy Predictive Response Markers in Diffuse Large B-Cell Lymphoma and Therapeutic Options After CART19 Failure.

Journal: Frontiers in immunology

Published: March 25, 2022

Memory stem T cells modified with a redesigned CD30-chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma.

Memory stem T cells modified with a redesigned CD30-chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma.

Journal: Clinical & translational immunology

Published: June 04, 2020

The novel agonistic iNKT-cell antibody NKT14m induces a therapeutic antitumor response against B-cell lymphoma.

The novel agonistic iNKT-cell antibody NKT14m induces a therapeutic antitumor response against B-cell lymphoma.

Journal: Oncoimmunology

Published: May 24, 2018

Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma.

Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma.

Journal: Journal of translational medicine

Published: March 16, 2017

A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy.

A short CD3/CD28 costimulation combined with IL-21 enhance the generation of human memory stem T cells for adoptive immunotherapy.

Journal: Journal of translational medicine

Published: April 05, 2016

Showing 1-8 of 8

Last Updated: 09/26/2026